HK1249439A1 - Pharmaceutical composition with improved storage stability and method for preparing the same - Google Patents
Pharmaceutical composition with improved storage stability and method for preparing the sameInfo
- Publication number
- HK1249439A1 HK1249439A1 HK18109124.0A HK18109124A HK1249439A1 HK 1249439 A1 HK1249439 A1 HK 1249439A1 HK 18109124 A HK18109124 A HK 18109124A HK 1249439 A1 HK1249439 A1 HK 1249439A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparing
- pharmaceutical composition
- same
- storage stability
- improved storage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/88—Post-polymerisation treatment
- C08G63/90—Purification; Drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/66—Polyesters containing oxygen in the form of ether groups
- C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
- C08G63/82—Preparation processes characterised by the catalyst used
- C08G63/823—Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
- C08G63/82—Preparation processes characterised by the catalyst used
- C08G63/85—Germanium, tin, lead, arsenic, antimony, bismuth, titanium, zirconium, hafnium, vanadium, niobium, tantalum, or compounds thereof
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20150106626 | 2015-07-28 | ||
| PCT/KR2016/008265 WO2017018816A1 (en) | 2015-07-28 | 2016-07-28 | Pharmaceutical composition with improved storage stability and method for preparing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1249439A1 true HK1249439A1 (en) | 2018-11-02 |
Family
ID=57884841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18109124.0A HK1249439A1 (en) | 2015-07-28 | 2018-07-13 | Pharmaceutical composition with improved storage stability and method for preparing the same |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3328434A4 (en) |
| JP (1) | JP6605706B2 (en) |
| KR (1) | KR101748191B1 (en) |
| CN (2) | CN106559983A (en) |
| AU (1) | AU2016299544A1 (en) |
| BR (1) | BR112018001736A2 (en) |
| CA (1) | CA2993920A1 (en) |
| HK (1) | HK1249439A1 (en) |
| IL (1) | IL257185A (en) |
| MX (1) | MX2018001219A (en) |
| RU (1) | RU2018107052A (en) |
| WO (1) | WO2017018816A1 (en) |
| ZA (1) | ZA201801189B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113424057B (en) * | 2019-04-19 | 2024-04-05 | 海正生物制药有限公司 | Detection method of poloxamer 188 in composition |
| KR20220082975A (en) * | 2020-12-10 | 2022-06-20 | 주식회사 삼양홀딩스 | Method for preparing polymeric micelle nanoparticle capable of reducing reconstitution time |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0180334B1 (en) | 1995-09-21 | 1999-03-20 | 김윤 | Drug messenger using el-2l-2 micelle and method for sealing drug to it |
| KR100360827B1 (en) * | 1999-08-14 | 2002-11-18 | 주식회사 삼양사 | Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| CN1233420C (en) * | 2000-05-12 | 2005-12-28 | 株式会社三养社 | Method for preparation of polymeric micelle via separation of block copolymer |
| US7217770B2 (en) * | 2000-05-17 | 2007-05-15 | Samyang Corporation | Stable polymeric micelle-type drug composition and method for the preparation thereof |
| EP1448707B1 (en) * | 2001-10-18 | 2007-08-22 | Samyang Corporation | Polymeric micelle composition with improved stability |
| US9801818B2 (en) * | 2007-12-31 | 2017-10-31 | Samyang Biopharmaceuticals Corporation | Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug |
| AU2008347720C1 (en) * | 2007-12-31 | 2012-01-19 | Samyang Holdings Corporation | Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof |
| KR101024742B1 (en) * | 2007-12-31 | 2011-03-24 | 주식회사 삼양사 | Amphiphilic Block Copolymer Micelle Composition Containing Taxane and Manufacturing Process of The Same |
| EP2201935B1 (en) * | 2008-12-26 | 2020-07-08 | Samyang Biopharmaceuticals Corporation | Polymeric micelle composition containing a poorly soluble drug and preparation method of the same |
| CN101444510B (en) | 2008-12-31 | 2011-03-09 | 南京卡文迪许生物工程技术有限公司 | Pharmaceutical preparation containing voriconazole and preparation method thereof |
| CN104761710B (en) * | 2014-02-14 | 2016-06-29 | 苏州海特比奥生物技术有限公司 | A kind of mPEG-PDLLA and preparation method thereof |
-
2016
- 2016-07-27 KR KR1020160095413A patent/KR101748191B1/en active IP Right Grant
- 2016-07-28 CN CN201680001936.3A patent/CN106559983A/en active Pending
- 2016-07-28 BR BR112018001736A patent/BR112018001736A2/en not_active Application Discontinuation
- 2016-07-28 CN CN202010292397.1A patent/CN111574702A/en active Pending
- 2016-07-28 JP JP2018504184A patent/JP6605706B2/en active Active
- 2016-07-28 EP EP16830849.2A patent/EP3328434A4/en active Pending
- 2016-07-28 CA CA2993920A patent/CA2993920A1/en not_active Abandoned
- 2016-07-28 RU RU2018107052A patent/RU2018107052A/en unknown
- 2016-07-28 WO PCT/KR2016/008265 patent/WO2017018816A1/en active Application Filing
- 2016-07-28 MX MX2018001219A patent/MX2018001219A/en unknown
- 2016-07-28 AU AU2016299544A patent/AU2016299544A1/en not_active Abandoned
-
2018
- 2018-01-28 IL IL257185A patent/IL257185A/en unknown
- 2018-02-21 ZA ZA2018/01189A patent/ZA201801189B/en unknown
- 2018-07-13 HK HK18109124.0A patent/HK1249439A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN111574702A (en) | 2020-08-25 |
| KR101748191B1 (en) | 2017-06-19 |
| EP3328434A1 (en) | 2018-06-06 |
| CA2993920A1 (en) | 2017-02-02 |
| JP2018521094A (en) | 2018-08-02 |
| AU2016299544A1 (en) | 2018-03-08 |
| ZA201801189B (en) | 2019-01-30 |
| IL257185A (en) | 2018-03-29 |
| WO2017018816A1 (en) | 2017-02-02 |
| KR20170015198A (en) | 2017-02-08 |
| RU2018107052A (en) | 2019-08-28 |
| CN106559983A (en) | 2017-04-05 |
| RU2018107052A3 (en) | 2019-08-28 |
| JP6605706B2 (en) | 2019-11-13 |
| BR112018001736A2 (en) | 2018-09-11 |
| MX2018001219A (en) | 2018-04-24 |
| EP3328434A4 (en) | 2019-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289099A (en) | Methods for the storage of whole blood, and compositions thereof | |
| EP3130355A4 (en) | Pharmaceutical composition containing pregabalin with improved stability and method for preparing same | |
| PL3337616T3 (en) | Pipette-tip-accommodating container and method for providing the same | |
| IL251703A0 (en) | Pharmaceutical composition with improved stability | |
| ZA201703398B (en) | Pharmaceutical composition and methods | |
| HRP20200104T8 (en) | Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same | |
| HK1214767A1 (en) | Tablet-formed pharmaceutical composition and preparation method thereof | |
| IL257621B (en) | Novel catechol derivatives and pharmaceutical composition comprising the same | |
| HK1249439A1 (en) | Pharmaceutical composition with improved storage stability and method for preparing the same | |
| HK1249442A1 (en) | Pharmaceutical composition with improved storage stability and method for preparing the same | |
| LT3250188T (en) | Pharmaceutical composition comprising aprepitant and method for the preparation thereof | |
| HK1249440A1 (en) | Pharmaceutical composition with improved storage stability and method for preparing the same | |
| EP3305283A4 (en) | Stabilized pharmaceutical composition and method for preparing same | |
| HK1249441A1 (en) | Pharmaceutical composition with improved storage stability and method for preparing the same | |
| EP3344661C0 (en) | Iron-polysaccharide complexes and methods for the preparation thereof | |
| IL230801A0 (en) | Stable sulfur-containing solid composition and method for manufacturing the same |